Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000038

CEO sold 289,774 shares at $29.16 ($8,449,810)

From the SEC's structured data for this filing

Trades in this filing

Gline Matthew · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-16 Sale : show line 1 in the form −289,774 $29.16 $8,449,810 16,736,116 D
Open-market sales · 289,774 sh · avg $29.16 · $8,449,810
Loading xslF345X06/wk-form4_1776724041.xml…